NCT05916508View on ClinicalTrials.gov

A Bleeding-Model Clinical Study

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

November 20, 2020

Study Completion Date

November 20, 2020

Conditions
Gingivitis
Interventions
DRUG

0.454% stannous fluoride

Brush two times daily

DRUG

0.76% sodium monofluorophosphate

Brush two times daily

DRUG

0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM

Brush two times daily

Trial Locations (1)

89146

Silverstone Research Group, Las Vegas

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT05916508 - A Bleeding-Model Clinical Study | Biotech Hunter | Biotech Hunter